Intraocular silicone prostheses in a dog and a horse with corneal lacerations.

This research article discusses the successful implementation of intraocular silicone prostheses in a horse and a dog that had suffered corneal lacerations, which contradicts previous beliefs that corneal disease was a hindrance to such procedures.

About the Research

• The study revolves around the implantation of intraocular silicone prostheses within the eyes of a horse and a dog. These animals had undergone traumatic corneal lacerations and displacement of intraocular contents, which led to the need for this sort of treatment.
• The researchers chiefly focused on the after-effects of the surgery conducted several months ago and investigated how the animals were handling the intraocular prostheses.
• Also, the research looked into the visual aesthetic of the animals post-surgery to judge whether or not the appearance after the implantation was cosmetically acceptable.

Findings of the Research

• A notable finding from the research was that contrary to prior assumptions, this study found that corneal disease does not pose a risk or inhibit the implantation of silicone prostheses. Previously, it was believed that corneal disease presented a contraindication, i.e., a condition or factor that serves as a reason to withhold a particular medical treatment due to the harm it would cause, for the implantation of these prostheses.
• Both the horse and the dog were tolerating the silicone prostheses in their eyes months after the surgery was performed showing no signs of serious complication or distress that could be directly associated with the implantation.
• The implantation of the silicone prostheses did not noticeably change the appearance of the animals’ eyes, thus making it a cosmetically acceptable solution.

Significance of the Research

• The research broadens the scope of treatment for animals suffering from traumatic corneal lacerations. It opens the possibility of using intraocular silicone prostheses as a sustainable and cosmetically acceptable solution.
• It also challenges previous studies that have cited corneal disease as a contraindication for this type of treatment and encourages further studies to confirm these findings.